Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.

Dermatology nursing / Dermatology Nurses' Association

Volumn 17, Issue 2, 2005, Pages 97-107

  Trent, Jennifer T ^a   Kerdel, Francisco A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; IMMUNOGLOBULIN G; INFLIXIMAB; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

BEHCET DISEASE; DRUG ANTAGONISM; GRAFT VERSUS HOST REACTION; HUMAN; PATHOPHYSIOLOGY; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; SKIN DISEASE; SUPPURATIVE HIDRADENITIS;

ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; DERMATOLOGIC AGENTS; GRAFT VS HOST DISEASE; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOGLOBULIN G; PSORIASIS; PYODERMA GANGRENOSUM; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20844438180     PISSN: 10603441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)